Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020)

The in vitro activities of gepotidacin and comparator agents against 3,560 Escherichia coli and 344 Staphylococcus saprophyticus collected from female (81.1%) and male (18.9%) patients with urinary tract infections (UTIs) in a global prospective surveillance program in 2019 to 2020 were determined....

Descripción completa

Detalles Bibliográficos
Autores principales: Arends, S. J. Ryan, Butler, Deborah, Scangarella-Oman, Nicole, Castanheira, Mariana, Mendes, Rodrigo E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Epidemiology and Surveillance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112209/
https://www.ncbi.nlm.nih.gov/pubmed/36877017
http://dx.doi.org/10.1128/aac.01525-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112209/
https://www.ncbi.nlm.nih.gov/pubmed/36877017
http://dx.doi.org/10.1128/aac.01525-22

Ejemplares similares